Research & Development: Page 69
-
PharmaVoice Team/PharmaVoice
Letter from the Editor
The appeal of the iPad… It’s hard not to be seduced by the power of the 9.7-inch, high-resolution LED-backlit IPS display and incredible multi-touch capabilities, all bundled in a sleek casing that is light enough to take anywhere. The iPad, what will Steve Jobs and his techno-creatives think of ...
By Taren Grom • Sept. 28, 2010 -
PharmaVoice Team/PharmaVoice
Comparative Effectiveness: Real-World Evidence of Outcomes
Comparative effectiveness research is going to have a huge impact on every stakeholder in healthcare delivery. It requires a much broader view of the healthcare system so that information will exist about a patient’s outcome as he or she moves from diagnosis to treatment in the healthcare system....
By PharmaVoice Team • Aug. 27, 2010 -
Explore the Trendline➔
Stock via Getty Images
TrendlineArtificial intelligence & machine learning
After years of excited buzz around the potential of artificial intelligence and machine learning, pharma has begun to realize the true implications and potential value of these technologies.
By PharmaVoice staff -
PharmaVoice Team/PharmaVoice
SHOWCASE FEATURE: No Longer Lost in Translation
As drug development continues to become more of a global endeavor, it’s more important than ever to ensure that documents, especially informed consent and other patient materials, are correctly translated into local languages to ensure the success of the trial. The increasing number of trials, as...
By PharmaVoice Team • Aug. 26, 2010 -
PharmaVoice Team/PharmaVoice
DIA Recap
DIA editor’s Choice Videos BBK Joan F. Bachenheimer and Matthew Stum Bioclinica Peter Benton Cognizant Nagaraja Srivatsan Cytel Irving Dark i3 Research Dr. Tracy Tsuetaki INC Research Alistair Macdonald Integrated Clinical Solutions Inc. J. Peter Armerding Kendle Ken Hintze, Ph.D. Kendle Drew Kil...
By PharmaVoice Team • Aug. 26, 2010 -
PharmaVoice Team/PharmaVoice
Dr. Leon Smith — Age of Excellence
Imagine an active and comfortable retirement, pursuing your hobbies at will and taking time to enjoy the golden years. Sound like fun? Not to Leon Smith, M.D., it doesn’t. After almost 55 years as a practicing physician, Dr. Smith is every bit as enthralled and impassioned about being a doctor ...
By Kim Ribbink • Aug. 26, 2010 -
PharmaVoice Team/PharmaVoice
Last Word
USING MONOCLONAL ANTIBODIES What are the opportunities for using monoclonal antibodies to treat Alzheimer’s disease? CHAIN: It took a long time to understand the hallmarks of Alzheimer’s disease. The beta amyloid plaques that appear in the brains of patients with Alzheimer’s are just a sign of wh...
By PharmaVoice Team • Aug. 26, 2010 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Sales, Marketing, and R&D Trends from Industry Analysts Featured Briefs: Pharma Could Benefit from Earlier Planning of Counter-Generics Strategies Sidebars: Counter-Generics Strategies Used by All Companies in Past 3 Years (2008-2010) Changes in Medical Treatment in Past Year Due to Economic ...
By PharmaVoice Team • Aug. 26, 2010 -
PharmaVoice Team/PharmaVoice
What's New
Barnett Educational Services has announced the release of updated editions of three of its market intelligence and clinical practices guides. PAREXEL’S BIOPHARMACEUTICAL R&D STATISTICAL SOURCEBOOK 2010/2011 includes statistics, trends, and proprietary market intelligence and analysis on the b...
By PharmaVoice Team • Aug. 26, 2010 -
PharmaVoice Team/PharmaVoice
UpFront
Chandler Chicco Co-Founder Receives SABRE Award Bob Chandler, principal and co-founder of the Chandler Chicco Companies, part of inVentiv Health, received a SABRE Award for Individual Achievement. Mr. Chandler received the award, which honors the exceptional work of public relations profession...
By PharmaVoice Team • Aug. 26, 2010 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Publisher Lisa Banket Editor Taren Grom Creative Director Marah Walsh Managing EDitor Denise Myshko Senior EDitor Robin Robinson features EDitor Kim Ribbink Contributing Editor Carolyn Gretton design associate Ariel Medel national account manager Cathy Tracy CIRCULATION Assistant Kathy Deiuliis C...
By Taren Grom • Aug. 26, 2010 -
PharmaVoice Team/PharmaVoice
Who's On The List by Section
The Commanders & Chiefs Johanna Allston, Ph.D. – bioCapture Vicente Anido Jr., Ph.D. – ISTA Pharmaceuticals Mara Aspinall – On-Q-ity Glenn Bilawsky – i3 Jay Bolling – Roska Healthcare David Brennan – AstraZeneca Nick Colucci – Publicis Healthcare – Communications Group Lynnette Cooke – Kantar...
By PharmaVoice Team • July 29, 2010 -
PharmaVoice Team/PharmaVoice
Lighter Moments
Michael Agard • Sanofi-Aventis US I was traveling for business in Paris with some colleagues. I had arranged a wake-up call with the hotel. My colleagues called about 1 a.m. to tell me about plans for the following day. Instead of listening to their phone call, I thought it was the wake-up call a...
By PharmaVoice Team • July 28, 2010 -
PharmaVoice Team/PharmaVoice
The Researchers & SCIENTISTS
A Diagnosis of Type 1 diabetes at the age of 6 and an early passion for science and research have propelled Randy Anderson, Ph.D., to become a force in the fight against the disease. Dr. Anderson has been making inroads into unraveling the mysteries of the disease since his senior-year zoology c...
By PharmaVoice Team • July 28, 2010 -
PharmaVoice Team/PharmaVoice
The ENTREPRENEURS
A New Breed of Explorer These stalwart captains of industry are taking their passion, innovation, and new ideas around improving the shortfalls within the industry to break new ground. Leslie Gaber started her company at her kitchen table with her 3 and 6 year old daughters by her side. Name: Les...
By PharmaVoice Team • July 28, 2010 -
PharmaVoice Team/PharmaVoice
The Commanders & CHIEFS
Johanna Allston, Ph.D. bioCapture Vicente Anido Jr., Ph.D. ISTA Pharmaceuticals Mara Aspinall On-Q-ity Glenn Bilawsky i3 Jay Bolling Roska Healthcare David Brennan AstraZeneca Nick Colucci Publicis Healthcare Communications Group Lynnette Cooke Kantar Health David Dunn ...
By PharmaVoice Team • July 28, 2010 -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharma POOL Dr. Mike BURGESS, Roche Dr. Mikael DOLSTEN, Pfizer Kenneth FRAZIER, Merck Adam SCHECHTER, Merck Biotechnology POOL Robert BRADWAY, Amgen Dr. Henry LI, Kylin Therapeutics Kenneth MOCH, Chimerix Dr. George PAINTER, Chimerix Dr. Thomas PITLER, Chimerix Biopharmaceutical POOL Dr. John ALA...
By PharmaVoice Team • July 28, 2010 -
PharmaVoice Team/PharmaVoice
On The Calendar
July 15-16 Effective Document Management for the Pharmaceutical, Biotech & Medical Device Industries The Hilton Hotel, Orange County/ Costa Mesa, Calif. The Center for Professional Innovation and Education, http://www.cfpie.com/showitem.aspx?productid=027&source=pv July 15-16 Managed Care...
By PharmaVoice Team • July 28, 2010 -
PharmaVoice Team/PharmaVoice
E-Media
New Electronic and Web-based Applications, Sites, and Technologies Featured Briefs: FDA, NIH Launch Electronic Safety Reporting Portal Insurance Documentation System Helps Prevent Study Delays GSW Worldwide Unveils New Website and Blog Derycz Scientific Offers Solution for Electronic Article Reus...
By PharmaVoice Team • July 28, 2010 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Sales, Marketing, and R&D Trends from Industry Analysts Featured Briefs: Financial Disclosure Compliance is Still an Issue for Life-Sciences Firms Sidebars: Slow Outsourcing of Disclosure Reporting Sources for Adverse Event Reports Online Collection of Adverse Event Reports Lags Traditional M...
By PharmaVoice Team • July 28, 2010 -
PharmaVoice Team/PharmaVoice
Who's on the List by Company
Anavex Life Sciences Cameron Durrant, M.D. 18 ApotheCom David Dunn 16 Astellas Pharma US Margaret Long 73 AstraZeneca David Brennan 46 bioCapture Johanna Allston, Ph.D. 12 C3i Robert Piwko 112 Cegedim Dendrite Angela Miccoli 74 Cipla Ltd. Yusuf Hamied, Ph.D. 19 ClearTrial Mike Soenen 29 closerloo...
By PharmaVoice Team • July 28, 2010 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
The PharmaVOICE 100: 2010 Every year, I think this is it, we’ve reached the pinnacle. And yet, every year, I continue to be amazed by the individuals whom our readers have identified as the most inspiring, motivating, and outstanding leaders in the life-sciences industry. This special issue, n...
By Taren Grom • July 28, 2010 -
PharmaVoice Team/PharmaVoice
Table of Contents
4 June 2 010 VIEW on Clinical Operations TAB LE OF CONTENTS Table of Contents 3 5 10 12 14 16 18 Letter from the Editor The Forum A Prescription for R&D Refills: Pharmaceutical and biotechnology drug developers appear to be making some progress in their perennial quest to bring more and bette...
By PharmaVoice Team • June 4, 2010 -
PharmaVoice Team/PharmaVoice
Innovating Imaging in Clinical Trials
Investigators engaged in drug or device discovery and development increasingly regard imaging modalities as technology to improve efficiencies, make faster go/no go decisions and reduce time-to-market. Beyond classic laboratory tests, medical images are raw datasets that empower the industry to i...
By PharmaVoice Team • June 4, 2010 -
PharmaVoice Team/PharmaVoice
Global Investigator Reimbursement and Protocol Complexity Trends
Some of the most significant trends in global clinical trial costs are occurring in the area of reimbursement for completed patients/subjects. Over the last five years, in phase II and III studies, reimbursement has increased globally by 30%. France and Germany show the highest percent increase, ...
By PharmaVoice Team • June 4, 2010 -
PharmaVoice Team/PharmaVoice
Finding the Best Clinical Trial Investigators
How many clinical trial investigators are in the United States, where are they, who are they, and how do you find the best ones? This article presents a newly completed project to answer these questions, and you will see comprehensive statistics that profile investigators. The best investigators ...
By PharmaVoice Team • June 4, 2010
Previous
